Who: Ginkgo BioWorks/Persephone Biosciences What: Synthetic biology specialist Ginkgo inked its third biotech collaboration of 2022, with a partnership to help Persephone develop and deliver novel
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Jazz Moves Into IO With Engineered IFN⍺